Stock Analysis on Net

Humana Inc. (NYSE:HUM)

$24.99

Cash Flow Statement

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Paying users area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Humana Inc., consolidated cash flow statement

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Net income
Gain on sale of Gentiva Hospice
(Gain) loss on investment securities, net
Gain on Kindred at Home equity method investment
Equity in net (earnings) losses
Stock-based compensation
Depreciation
Amortization
Impairment of property and equipment
Impairment of intangible assets
Deferred income taxes
Receivables
Other assets
Benefits payable
Other liabilities
Unearned revenues
Changes in operating assets and liabilities, net of effect of businesses acquired and dispositions
Other, net
Adjustments to reconcile net income to net cash provided by operating activities
Net cash provided by operating activities
Proceeds from sale of Gentiva Hospice, net
Acquisitions, net of cash and cash equivalents acquired
Purchases of property and equipment
Proceeds from sale of property and equipment
Purchases of investment securities
Proceeds from maturities of investment securities
Proceeds from sales of investment securities
Net cash used in investing activities
Receipts (withdrawals) from contract deposits, net
Proceeds from issuance of senior notes, net
Repayment of senior notes
Proceeds from issuance (repayments) of commercial paper, net
Proceeds from short-term borrowings
Repayment of short-term borrowings
Proceeds from term loan
Repayment of term loan
Debt issue costs
Common stock repurchases
Dividends paid
Change in book overdraft
Other, net
Net cash provided by (used in) financing activities
Increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Cash flow statement item Description The company
Net cash provided by operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Humana Inc. net cash provided by operating activities increased from 2021 to 2022 but then slightly decreased from 2022 to 2023.
Net cash used in investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Humana Inc. net cash used in investing activities increased from 2021 to 2022 but then slightly decreased from 2022 to 2023.
Net cash provided by (used in) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Humana Inc. net cash provided by (used in) financing activities decreased from 2021 to 2022 but then slightly increased from 2022 to 2023.